Abstract
Introduction
Obese patients who fail primary surgical management of gastroesophageal reflux present a significant challenge. We reviewed our outcomes with reoperative reflux surgery in obese (body mass index (BMI) >30) and nonobese patients to identify predictors of failure and complications and evaluate whether reoperative fundoplication is the ideal solution for obese patients.
Methods
We conducted a retrospective review of consecutive patients undergoing reoperation for failed anti-reflux surgery between 1994 and 2013. Medical record review identified preoperative, intraoperative, and postoperative characteristics. Short- and long-term outcomes for obese and nonobese patients were compared using descriptive statistics and logistic regression.
Results
One hundred and nine interventions were identified in 95 patients. Clinical characteristics were similar between obese and nonobese patients. Eighty-eight (83.8 %) patients underwent laparoscopic repair, 87 (79.8 %) of whom had a Nissen fundoplication. Obese patients were more likely to fail via a slipped wrap (64.7 vs. 40.0 %; p = 0.02). No differences were seen in short- or long-term symptomatic relief or major complications. In bivariate analysis, short-term outcomes were predicted by preoperative albumin <3.5 mg/dL (odds ratio (OR), 0.27 (confidence interval (CI), 0.08–0.96); p = 0.04) and laparoscopic conversion (OR, 0.19 (CI, 0.04–1.03); p = 0.05). Laparoscopic conversion was associated with major complications (OR, 7.33 (CI, 1.33–40.55); p = 0.02). BMI was a significant predictor for long-term outcome (p = 0.03) as a continuous variable in sensitivity analyses.
Conclusions
Obese patients with recurrence after failed anti-reflux operation may be safely treated with a repeat operation. Our data indicate no difference in outcomes for patients with BMI >30, underscoring the importance of preoperative discussion as to the best approach: reoperative fundoplication or a gastric bypass.
Similar content being viewed by others
References
Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc. 1991;1 (3):138–143.
Furnee EJ, Draaisma WA, Broeders IA, Gooszen HG. Surgical reintervention after failed antireflux surgery: a systematic review of the literature. J Gastrointest Surg. 2009;13 (8):1539–1549.
Khajanchee YS, O’Rourke R, Cassera MA, Gatta P, Hansen PD, Swanstrom LL. Laparoscopic reintervention for failed antireflux surgery: subjective and objective outcomes in 176 consecutive patients. Arch Surg. 2007;142(8):785–901; discussion 791–2.
Bais JE, Horbach TL, Masclee AA, Smout AJ, Terpstra JL, Gooszen HG. Surgical treatment for recurrent gastro-oesophageal reflux disease after failed antireflux surgery. Br J Surg. 2000;87(2):243-249X.
Furnee EJ, Draaisma WA, Broeders IA, Smout AJ, Gooszen HG. Surgical reintervention after antireflux surgery for gastroesophageal reflux disease: a prospective cohort study in 130 patients. Arch Surg. 2008;143(3):267–74; discussion 274.
Dutta S, Bamehriz F, Boghossian T, Pottruff CG, Anvari M. Outcome of laparoscopic redo fundoplication. Surg Endosc. 2004;18(3):440–443.
Draaisma WA, Rijnhart-de Jong HG, Broeders IA, Smout AJ, Furnee EJ, Gooszen HG. Five-year subjective and objective results of laparoscopic and conventional nissen fundoplication: a randomized trial. Ann Surg. 2006;244(1):34–41.
Davis CS, Baldea A, Johns JR, Joehl RJ, Fisichella PM. The evolution and long-term results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease. JSLS. 2010;14(3):332–341.
Finley RJ. Reoperative antireflux surgery. Chest Surg Clin N Am. 2001;11(3):583–7, vii.
Awais O, Luketich JD, Schuchert MJ, et al. Reoperative antireflux surgery for failed fundoplication: an analysis of outcomes in 275 patients. Ann Thorac Surg. 2011;92(3):1083–9; discussion 1089–90.
Fisher BL, Pennathur A, Mutnick JL, Little AG. Obesity correlates with gastroesophageal reflux. Dig Dis Sci. 1999;44(11):2290–2294.
Mittal SK, Legner A, Tsuboi K, Juhasz A, Bathla L, Lee TH. Roux-en-Y reconstruction is superior to redo fundoplication in a subset of patients with failed antireflux surgery. Surg Endosc. 2013;27(3):927–935.
Stefanidis D, Navarro F, Augenstein VA, Gersin KS, Heniford BT. Laparoscopic fundoplication takedown with conversion to roux-en-Y gastric bypass leads to excellent reflux control and quality of life after fundoplication failure. Surg Endosc. 2012;26(12):3521–3527.
Society of American Gastrointestinal and Endoscopic Surgeons. Guidelines for clinical application of laparoscopic bariatric surgery. http://www.sages.org/publications/guidelines/guidelines-for-clinical-application-of-laparoscopic-bariatric-surgery/. Published 20 March 2008. Updated 2008. Accessed 27 March 2014.
Center for Disease Control. Defining overweight and obesity. Defining Overweight and Obesity Web site. http://www.cdc.gov/obesity/adult/defining.html. Updated 2012. Accessed 27 February 2012, 2014.
Tekin K, Toydemir T, Yerdel MA. Is laparoscopic antireflux surgery safe and effective in obese patients? Surg Endosc. 2012;26(1):86–95.
Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc. 2001;15(9):986–989.
Anvari M, Bamehriz F. Outcome of laparoscopic nissen fundoplication in patients with body mass index ≥ or =35. Surg Endosc. 2006;20(2):230–234.
Winslow ER, Frisella MM, Soper NJ, Klingensmith ME. Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc. 2003;17(12):2003–2011.
Zainabadi K, Courcoulas AP, Awais O, Raftopoulos I. Laparoscopic revision of nissen fundoplication to roux-en-Y gastric bypass in morbidly obese patients. Surg Endosc. 2008;22(12):2737–2740.
Raftopoulos I, Awais O, Courcoulas AP, Luketich JD. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: Initial experience. Obes Surg. 2004;14(10):1373–1380.
Patterson EJ, Davis DG, Khajanchee Y, Swanstrom LL. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc. 2003;17(10):1561–1565.
Furnee EJ, Draaisma WA, Broeders IA, Smout AJ, Vlek AL, Gooszen HG. Predictors of symptomatic and objective outcomes after surgical reintervention for failed antireflux surgery. Br J Surg. 2008;95(11):1369–1374.
Deschamps C, Trastek VF, Allen MS, Pairolero PC, Johnson JO, Larson DR. Long-term results after reoperation for failed antireflux procedures. J Thorac Cardiovasc Surg. 1997;113(3):545–50; discussion 550–1.
Vignal JC, Luc G, Wagner T, Cunha AS, Collet D. Re-operation for failed gastro-esophageal fundoplication. what results to expect? J Visc Surg. 2012;149(1):e61–5.
Pagé MP, Kastenmeier A, Goldblatt M, Frelich M, Bosler M, Wallace J, Gould J. Medically refractory gastroesophageal reflux disease in the obese: what is the best surgical approach? Surg Endosc. 2014; 28(5):1500–4.
Conflict of Interest
The authors have no disclosures relevant to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Appendices
Appendix 1
Appendix 2
Rights and permissions
About this article
Cite this article
Wakeam, E., Wee, J., Lebenthal, A. et al. Does BMI Predict Recurrence or Complications After Reoperative Reflux Surgery? Review of a Single Center’s Experience and a Comparison of Outcomes. J Gastrointest Surg 18, 1965–1973 (2014). https://doi.org/10.1007/s11605-014-2656-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-014-2656-4